Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
9,130.00
-70.00 (-0.76%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2009 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2009 - 2019 |
| Circulatory System | 108.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Circulatory System Growth | 21.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Solvent | 60.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Solvent Growth | 3.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System Solvent | 29.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System Solvent Growth | 8.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Foods, Etc | 15.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 56.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 14.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antipyretic Analgesic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2009 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2009 - 2019 |
| South Korea | 266.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 16.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 4.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | -15.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|